Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and Azenta (AZTA)
Analysts fell to the sidelines weighing in on Henry Schein (HSIC – Research Report) and Azenta (AZTA – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Henry Schein (HSIC)
William Blair analyst Brandon Vazquez maintained a Hold rating on Henry Schein today. The company’s shares closed last Wednesday at $74.90.
According to TipRanks.com, Vazquez is a 3-star analyst with an average return of
Currently, the analyst consensus on Henry Schein is a Moderate Buy with an average price target of $79.75, representing an 8.5% upside. In a report issued on January 20, Mizuho Securities also maintained a Hold rating on the stock with a $81.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Azenta (AZTA)
TD Cowen analyst Brendan Smith maintained a Hold rating on Azenta today and set a price target of $30.00. The company’s shares closed last Wednesday at $28.68.
According to TipRanks.com, Smith is a 4-star analyst with an average return of
Azenta has an analyst consensus of Moderate Buy, with a price target consensus of $40.33, a 25.8% upside from current levels. In a report issued on January 22, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $41.00 price target.
